• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症肌无力中乙酰胆碱受体抗体的测定:临床应用及发病机制意义

Determination of acetylcholine receptor antibody in myasthenia gravis: clinical usefulness and pathogenetic implications.

作者信息

Lefvert A K, Bergström K, Matell G, Osterman P O, Pirskanen R

出版信息

J Neurol Neurosurg Psychiatry. 1978 May;41(5):394-403. doi: 10.1136/jnnp.41.5.394.

DOI:10.1136/jnnp.41.5.394
PMID:207825
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC493044/
Abstract

Antibodies to cholinergic receptor structures were found in 75% of 76 Finnish and 93% of 175 Swedish patients with myasthenia gravis. The amount of antibodies showed a positive correlation to the severity of the disease, and was reduced during immunosuppressive treatment, and by thymectomy. Thymoma patients had high values. The antibody was also found in the cerebrospinal fluid. Two healthy newborn babies of myasthenic mothers had antibodies during the first weeks of life, in spite of no clinical symptoms. The occurrence of IgM antibodies before IgM antibodies in two patients during the early stages of myasthenia gravis suggests that the antibody is not a primary cause of the disease.

摘要

在76名芬兰重症肌无力患者中,75%发现了针对胆碱能受体结构的抗体;在175名瑞典重症肌无力患者中,93%发现了此类抗体。抗体数量与疾病严重程度呈正相关,在免疫抑制治疗期间以及胸腺切除术后会减少。胸腺瘤患者的抗体值较高。在脑脊液中也发现了该抗体。两名患重症肌无力母亲的健康新生儿在出生后的头几周内虽无临床症状,但也有抗体。两名重症肌无力早期患者先出现IgM抗体,后出现IgG抗体,这表明该抗体并非疾病的主要病因。

相似文献

1
Determination of acetylcholine receptor antibody in myasthenia gravis: clinical usefulness and pathogenetic implications.重症肌无力中乙酰胆碱受体抗体的测定:临床应用及发病机制意义
J Neurol Neurosurg Psychiatry. 1978 May;41(5):394-403. doi: 10.1136/jnnp.41.5.394.
2
Acetylcholine receptor antibodies in the diagnosis of human and experimental myasthenia gravis.乙酰胆碱受体抗体在人类及实验性重症肌无力诊断中的应用
Muscle Nerve. 1978 Sep-Oct;1(5):427-31. doi: 10.1002/mus.880010518.
3
Anti-acetylcholine-receptor antibody concentrations after thymectomy in patients with myasthenia gravis.重症肌无力患者胸腺切除术后抗乙酰胆碱受体抗体浓度
Br Med J. 1978 Oct 14;2(6144):1051-3. doi: 10.1136/bmj.2.6144.1051.
4
The effect of thoracic duct lymph drainage in myasthenia gravis.
Eur Neurol. 1973;9(3):157-67. doi: 10.1159/000114221.
5
Myasthenia gravis, thymectomy, and antiacetycholine receptor antibody.重症肌无力、胸腺切除术和抗乙酰胆碱受体抗体
J Neurol. 1980;224(1):9-15. doi: 10.1007/BF00313202.
6
No direct correlation between serum antiacetylcholine receptor antibody levels and clinical state of individual patients with myasthenia gravis.重症肌无力患者血清抗乙酰胆碱受体抗体水平与个体临床状态之间无直接相关性。
Neurology. 1981 Feb;31(2):220-4. doi: 10.1212/wnl.31.2.220.
7
[Amount of circulating acetylcholine receptor antibodies in the course of myasthenia, following thymectomy and in immunosuppressive therapy].[重症肌无力病程中、胸腺切除术后及免疫抑制治疗过程中循环乙酰胆碱受体抗体的含量]
Nervenarzt. 1984 Aug;55(8):426-31.
8
[Clinical and biological evolution of myasthenia gravis after thymectomy in a 13-year-old girl].
Helv Paediatr Acta. 1979 Sep;34(4):375-80.
9
Acetylcholine receptor turnover in myasthenia gravis.重症肌无力中乙酰胆碱受体的周转
Am J Physiol. 1982 Jul;243(1):E31-6. doi: 10.1152/ajpendo.1982.243.1.E31.
10
Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis.重症肌无力的血浆置换和免疫抑制药物治疗
N Engl J Med. 1977 Nov 24;297(21):1134-40. doi: 10.1056/NEJM197711242972102.

引用本文的文献

1
Pregnancy outcomes for women with myasthenia gravis and their newborns: A nationwide register-based cohort study.患有重症肌无力的女性及其新生儿的妊娠结局:一项全国范围内基于登记的队列研究。
Eur J Neurol. 2024 Jan;31(1):e16100. doi: 10.1111/ene.16100. Epub 2023 Oct 16.
2
Heterogeneity of Acetylcholine Receptor Autoantibody-Mediated Complement Activity in Patients With Myasthenia Gravis.乙酰胆碱受体自身抗体介导的补体活性在重症肌无力患者中的异质性。
Neurol Neuroimmunol Neuroinflamm. 2022 Apr 26;9(4). doi: 10.1212/NXI.0000000000001169. Print 2022 Jul.
3
Myasthenia gravis complement activity is independent of autoantibody titer and disease severity.重症肌无力补体活性与自身抗体滴度和疾病严重程度无关。
PLoS One. 2022 Mar 15;17(3):e0264489. doi: 10.1371/journal.pone.0264489. eCollection 2022.
4
C3, C5a and anti-acetylcholine receptor antibody as severity biomarkers in myasthenia gravis.补体C3、C5a及抗乙酰胆碱受体抗体作为重症肌无力严重程度的生物标志物
Ther Adv Neurol Disord. 2020 Aug 10;13:1756286420935697. doi: 10.1177/1756286420935697. eCollection 2020.
5
Bortezomib in antibody-mediated autoimmune diseases (TAVAB): study protocol for a unicentric, non-randomised, non-placebo controlled trial.硼替佐米治疗抗体介导的自身免疫性疾病(TAVAB):一项单中心、非随机、非安慰剂对照试验的研究方案。
BMJ Open. 2019 Jan 28;9(1):e024523. doi: 10.1136/bmjopen-2018-024523.
6
The Use of Human Mesenchymal Stem Cells as Therapeutic Agents for the Treatment of Immune-Related Diseases: A Systematic Review.人骨髓间充质干细胞作为治疗免疫相关性疾病的治疗剂的应用:系统评价。
Front Immunol. 2018 Sep 11;9:2056. doi: 10.3389/fimmu.2018.02056. eCollection 2018.
7
Immunoadsorption versus plasma exchange versus combination for treatment of myasthenic deterioration.免疫吸附与血浆置换及联合治疗用于重症肌无力病情恶化的治疗比较
Ther Adv Neurol Disord. 2016 Jul;9(4):297-303. doi: 10.1177/1756285616637046. Epub 2016 Mar 10.
8
Both binding and blocking antibodies correlate with disease severity in myasthenia gravis.在重症肌无力中,结合抗体和阻断抗体均与疾病严重程度相关。
Neurol Sci. 2015 Jul;36(7):1167-71. doi: 10.1007/s10072-015-2236-8. Epub 2015 May 12.
9
Muscle autoantibodies in myasthenia gravis: beyond diagnosis?重症肌无力中的肌肉自身抗体:超越诊断?
Expert Rev Clin Immunol. 2012 Jul;8(5):427-38. doi: 10.1586/eci.12.34.
10
Recombinant expression of the AChR-alpha1 subunit for the detection of conformation-dependent epitopes in Myasthenia Gravis.用于检测重症肌无力中构象依赖性表位的 AChR-α1 亚基的重组表达。
Neuromuscul Disord. 2011 Mar;21(3):204-13. doi: 10.1016/j.nmd.2010.12.003. Epub 2010 Dec 30.

本文引用的文献

1
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
2
Preparation of iodine-131 labelled human growth hormone of high specific activity.高比活度碘-131标记人生长激素的制备
Nature. 1962 May 5;194:495-6. doi: 10.1038/194495a0.
3
STUDIES IN MYASTHENIA GRAVIS. 1. A CLINICAL STUDY OF 180 PATIENTS.重症肌无力研究。1. 180例患者的临床研究。
J Neurol Sci. 1964 Nov-Dec;1(6):512-46. doi: 10.1016/0022-510x(64)90171-6.
4
Studies in neuromuscular function. IV. Stimulating and depressant effects of acetylcholine and choline in patients with myasthenia gravis, and their relationship to the defect in neuromuscular transmission.神经肌肉功能研究。IV. 乙酰胆碱和胆碱对重症肌无力患者的刺激和抑制作用及其与神经肌肉传递缺陷的关系。
Bull Johns Hopkins Hosp. 1956 Sep;99(3):153-81.
5
Serum globulin in myasthenia gravis: inhibition of alpha-bungarotoxin binding to acetylcholine receptors.重症肌无力中的血清球蛋白:对α-银环蛇毒素与乙酰胆碱受体结合的抑制作用
Science. 1974 Oct 4;186(4158):55-7. doi: 10.1126/science.186.4158.55.
6
The effect of thoracic duct lymph drainage in myasthenia gravis.
Eur Neurol. 1973;9(3):157-67. doi: 10.1159/000114221.
7
Intestinal lymphangiectasia: a protein-losing enteropathy with hypogammaglobulinemia, lymphocytopenia and impaired homograft rejection.肠淋巴管扩张症:一种伴有低丙种球蛋白血症、淋巴细胞减少和同种异体移植排斥反应受损的蛋白丢失性肠病。
J Clin Invest. 1967 Oct;46(10):1643-56. doi: 10.1172/JCI105656.
8
Acetylcholine receptor antibodies in myasthenia gravis.重症肌无力中的乙酰胆碱受体抗体
N Engl J Med. 1975 Oct 9;293(15):760-1. doi: 10.1056/NEJM197510092931508.
9
Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value.重症肌无力中乙酰胆碱受体抗体。患病率、临床相关性及诊断价值。
Neurology. 1976 Nov;26(11):1054-9. doi: 10.1212/wnl.26.11.1054.
10
An assay for antibodies to human acetylcholine receptor in serum from patients with myasthenia gravis.重症肌无力患者血清中抗人乙酰胆碱受体抗体的检测方法。
Clin Immunol Immunopathol. 1977 Jan;7(1):36-43. doi: 10.1016/0090-1229(77)90027-7.